BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38768344)

  • 1. Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
    Wu C; Raheem IT; Nahas DD; Citron M; Kim PS; Montefiori DC; Ottinger EA; Hepler RW; Hrin R; Patel SB; Soisson SM; Joyce JG
    Proc Natl Acad Sci U S A; 2024 May; 121(22):e2317230121. PubMed ID: 38768344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.
    Rubio AA; Filsinger Interrante MV; Bell BN; Brown CL; Bruun TUJ; LaBranche CC; Montefiori DC; Kim PS
    J Virol; 2021 Jul; 95(15):e0235020. PubMed ID: 33980592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.
    Nelson JD; Kinkead H; Brunel FM; Leaman D; Jensen R; Louis JM; Maruyama T; Bewley CA; Bowdish K; Clore GM; Dawson PE; Frederickson S; Mage RG; Richman DD; Burton DR; Zwick MB
    Virology; 2008 Jul; 377(1):170-83. PubMed ID: 18499210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.
    Kumar S; Lin X; Ngo T; Shapero B; Sou C; Allen JD; Copps J; Zhang L; Ozorowski G; He L; Crispin M; Ward AB; Wilson IA; Zhu J
    mBio; 2021 Jun; 12(3):e0042921. PubMed ID: 34156262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
    Montefiori DC; Filsinger Interrante MV; Bell BN; Rubio AA; Joyce JG; Shiver JW; LaBranche CC; Kim PS
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes.
    Leaman DP; Stano A; Chen Y; Zhang L; Zwick MB
    J Virol; 2021 Jun; 95(13):e0000521. PubMed ID: 33883221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
    Vassell R; He Y; Vennakalanti P; Dey AK; Zhuang M; Wang W; Sun Y; Biron-Sorek Z; Srivastava IK; LaBranche CC; Montefiori DC; Barnett SW; Weiss CD
    PLoS One; 2015; 10(6):e0128562. PubMed ID: 26087072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-guided stabilization improves the ability of the HIV-1 gp41 hydrophobic pocket to elicit neutralizing antibodies.
    Bruun TUJ; Tang S; Erwin G; Deis L; Fernandez D; Kim PS
    J Biol Chem; 2023 Apr; 299(4):103062. PubMed ID: 36841484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41.
    Sabin C; Corti D; Buzon V; Seaman MS; Lutje Hulsik D; Hinz A; Vanzetta F; Agatic G; Silacci C; Mainetti L; Scarlatti G; Sallusto F; Weiss R; Lanzavecchia A; Weissenhorn W
    PLoS Pathog; 2010 Nov; 6(11):e1001195. PubMed ID: 21124990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development.
    Malherbe DC; Wibmer CK; Nonyane M; Reed J; Sather DN; Spencer DA; Schuman JT; Guo B; Pandey S; Robins H; Park B; Fuller DH; Sacha JB; Moore PL; Hessell AJ; Haigwood NL
    Front Immunol; 2020; 11():984. PubMed ID: 32582155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards the development of a HIV-1 gp41-directed vaccine.
    McGaughey GB; Barbato G; Bianchi E; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller MD; Pessi A; Shiver JW; Bogusky MJ
    Curr HIV Res; 2004 Apr; 2(2):193-204. PubMed ID: 15078183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
    Lai RP; Hock M; Radzimanowski J; Tonks P; Hulsik DL; Effantin G; Seilly DJ; Dreja H; Kliche A; Wagner R; Barnett SW; Tumba N; Morris L; LaBranche CC; Montefiori DC; Seaman MS; Heeney JL; Weissenhorn W
    J Biol Chem; 2014 Oct; 289(43):29912-26. PubMed ID: 25160627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.
    van Haaren MM; McCoy LE; Torres JL; Lee W; Cottrell CA; Copps JL; van der Woude P; Yasmeen A; de Taeye SW; Torrents de la Peña A; Moore JP; Burton DR; Klasse PJ; Ward AB; Sanders RW; van Gils MJ
    J Virol; 2021 Aug; 95(17):e0009421. PubMed ID: 34076487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
    Kim S; Filsinger Interrante MV; Kim PS
    J Virol; 2023 Jan; 97(1):e0164722. PubMed ID: 36541800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
    Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41.
    Gustchina E; Li M; Louis JM; Anderson DE; Lloyd J; Frisch C; Bewley CA; Gustchina A; Wlodawer A; Clore GM
    PLoS Pathog; 2010 Nov; 6(11):e1001182. PubMed ID: 21085615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
    Virology; 2017 May; 505():113-126. PubMed ID: 28237764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
    Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.